Nadia Nicholine Poulsen

Nadia Nicholine Poulsen

Auto-generated profile, based on publicly available information

Nadia Nicholine Poulsen

Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
NPNadia Nicholine Poulsen
Nadia Nicholine Poulsen
ABAlbrecht von Brunn
Albrecht von Brunn
MHMads Hornum
Mads Hornum
MJMartin Blomberg Jensen
Martin Blomberg Jensen
The coronavirus disease 2019 (COVID‐19) pandemic is declared a global health emergency. COVID‐19 is triggered by a novel coronavirus: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV2). Baseline characteristics of admitted patients with COVID‐19 show that adiposity, diabetes and hypertension are risk factors for developing severe disease, but so far immunosuppressed patients that are listed as high‐risk patients have not been more susceptible to severe COVID‐19 than the rest of the population. Multiple clinical trials are currently being conducted, which hopefully can identify more drugs that can lower mortality, morbidity and burden on the society. Several independent studies have convincingly shown that cyclosporine inhibit replication of several different coronaviruses in vitro . The cyclosporine‐analog Alisporivir has recently been shown to inhibit SARS‐CoV2 in vitro . These findings are intriguing, although there is no clinical evidence for a protective effect to reduce the likelihood of severe COVID‐19 or to treat the immune storm or adult respiratory distress syndrome (ARDS) that often causes severe morbidity. Here, we review the putative link between COVID‐19 and cyclosporine, while we await more robust clinical data.

30 July 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
LHLasse Bøllehuus Hansen
Lasse Bøllehuus Hansen
JKJovana Kaludjerovic
Jovana Kaludjerovic
JNJohn Erik Nielsen
John Erik Nielsen
ARAnders Rehfeld
Anders Rehfeld
NPNadia Nicholine Poulsen
Nadia Nicholine Poulsen
MJMartin Blomberg Jensen
Martin Blomberg Jensen
Currently, no treatment exists to improve semen quality in most infertile men. Here, we demonstrate systemic and direct effects of Fibroblast growth factor 23 (FGF23) and Klotho, which normally regulate vitamin D and mineral homeostasis, on testicular function. Direct effects are plausible because KLOTHO is expressed in both germ cells and spermatozoa and forms with FGFR1 a specific receptor for the bone‐derived hormone FGF23. Treatment with FGF23 increased testicular weight in wild‐type mice, while mice with global loss of either FGF23 or Klotho had low testicular weight, reduced sperm count, and sperm motility. Mice with germ cell‐specific Klotho (gcKL) deficiency neither had a change in sperm count nor sperm motility. However, a tendency toward fewer pregnancies was detected, and significantly fewer Klotho heterozygous pups originated from gcKL knockdown mice than would be expected by mendelian inheritance. Moreover, gcKL mice had a molecular phenotype with higher testicular expression of Slc34a2 and Trpv5 than wild‐type littermates, which suggests a regulatory role for testicular phosphate and calcium homeostasis. KLOTHO and FGFR1 were also expressed in human germ cells and spermatozoa, and FGF23 treatment augmented the calcium response to progesterone in human spermatozoa. Moreover, cross‐sectional data revealed that infertile men with the highest serum Klotho levels had significantly higher serum Inhibin B and total sperm count than men with the lowest serum Klotho concentrations. In conclusion, this translational study suggests that FGF23 and Klotho influence gonadal function and testicular mineral ion homeostasis both directly and indirectly through systemic changes in vitamin D and mineral homeostasis.

1 February 2017 in Respiratory Medicine
Verified
Journal Article
Closed access
ABAsger Bjerregaard
Asger Bjerregaard
ILIngrid A. Laing
Ingrid A. Laing
NPNadia Poulsen
Nadia Poulsen
VBVibeke Backer
Vibeke Backer
ASAsger Sverrild
Asger Sverrild
CPCeleste Porsbjerg
Celeste Porsbjerg

1 July 2018 in Respiratory Medicine
Verified
Journal Article
Closed access
NPNadia Nicholine Poulsen
Nadia Nicholine Poulsen
ABAsger Bjerregaard
Asger Bjerregaard
SKSiew-Kim Khoo
Siew-Kim Khoo
ILIngrid A. Laing
Ingrid A. Laing
PSPeter Le Souëf
Peter Le Souëf
CPCeleste Porsbjerg
Celeste Porsbjerg